| scholarly article | Q13442814 |
| P50 | author | Jean-François Dumas | Q61828691 |
| Caroline Goupille | Q97564567 | ||
| Michelle Pinault | Q114326949 | ||
| Cécile Berri | Q125132798 | ||
| Sophie Tesseraud | Q125132834 | ||
| Stéphane Servais | Q57770670 | ||
| P2093 | author name string | Anne Collin | |
| Charles Couet | |||
| Cloé M Julienne | |||
| P2860 | cites work | Dystrophin glycoprotein complex dysfunction: A regulatory link between muscular dystrophy and cancer cachexia | Q58492188 |
| Skeletal muscle UCP2 and UCP3 gene expression in a rat cancer cachexia model | Q60403913 | ||
| Myofibrillar ATPase histochemistry of rat skeletal muscles: a "two-dimensional" quantitative approach | Q67898641 | ||
| Differential reconstitution of mitochondrial respiratory chain activity and plasma redox state by cysteine and ornithine in a model of cancer cachexia | Q78029758 | ||
| n-3 PUFA-enriched diet delays the occurrence of cancer cachexia in rat with peritoneal carcinosis | Q83970205 | ||
| Muscle UCP-3 mRNA levels are elevated in weight loss associated with gastrointestinal adenocarcinoma in humans | Q24643188 | ||
| A new mathematical model for relative quantification in real-time RT-PCR | Q27860781 | ||
| Disruption of the uncoupling protein-2 gene in mice reveals a role in immunity and reactive oxygen species production | Q28139177 | ||
| Contribution of peroxidized cardiolipin to inactivation of bovine heart cytochrome c oxidase | Q33248509 | ||
| Redox balance and carbonylated proteins in limb and heart muscles of cachectic rats. | Q33500784 | ||
| Mechanisms to explain wasting of muscle and fat in cancer cachexia | Q34013222 | ||
| Mechanisms of cancer cachexia | Q34016887 | ||
| New extension of the Mitchell Theory for oxidative phosphorylation in mitochondria of living organisms | Q34017346 | ||
| Cellular energy utilization and molecular origin of standard metabolic rate in mammals | Q34433543 | ||
| Muscle oxidative capacity during IL-6-dependent cancer cachexia. | Q34598672 | ||
| Intramyocellular lipid droplets increase with progression of cachexia in cancer patients | Q35053586 | ||
| Microarray analysis suggests that burn injury results in mitochondrial dysfunction in human skeletal muscle | Q35513839 | ||
| Expression of uncoupling proteins-1, -2 and -3 mRNA is induced by an adenocarcinoma-derived lipid-mobilizing factor | Q36644080 | ||
| Cancer cachexia signaling pathways continue to emerge yet much still points to the proteasome | Q36749044 | ||
| Mitochondrial function and substrate availability | Q36916469 | ||
| Nuclear magnetic resonance in conjunction with functional genomics suggests mitochondrial dysfunction in a murine model of cancer cachexia | Q37016738 | ||
| Effect of aging, caloric restriction, and uncoupling protein 3 (UCP3) on mitochondrial proton leak in mice | Q37039107 | ||
| Role of the ubiquitin-proteasome pathway in muscle atrophy in cachexia | Q37345273 | ||
| The role of cardiolipin in the structural organization of mitochondrial membranes | Q37376400 | ||
| Is skeletal muscle mitochondrial dysfunction a cause or an indirect consequence of insulin resistance in humans? | Q37435227 | ||
| Uncoupling proteins: a complex journey to function discovery. | Q37559484 | ||
| Ethical guidelines for authorship and publishing in the Journal of Cachexia, Sarcopenia and Muscle | Q37863021 | ||
| Uncoupling proteins and the control of mitochondrial reactive oxygen species production | Q37901603 | ||
| Efficiency of oxidative phosphorylation in liver mitochondria is decreased in a rat model of peritoneal carcinosis. | Q39629174 | ||
| Tissue variation in the control of oxidative phosphorylation: implication for mitochondrial diseases | Q42996199 | ||
| Hyperlipemia: a role in regulating UCP3 gene expression in skeletal muscle during cancer cachexia? | Q43744117 | ||
| Mitochondrial respiratory chain adjustment to cellular energy demand | Q43752287 | ||
| Effect of voluntary exercise on H2O2 release by subsarcolemmal and intermyofibrillar mitochondria. | Q44491179 | ||
| Food restriction affects energy metabolism in rat liver mitochondria. | Q44738872 | ||
| Selection for rapid growth increases the number and the size of muscle fibres without changing their typing in chickens | Q47356928 | ||
| Increased expression of proteasome subunits in skeletal muscle of cancer patients with weight loss. | Q47370718 | ||
| Long-term caloric restriction increases UCP3 content but decreases proton leak and reactive oxygen species production in rat skeletal muscle mitochondria | Q47799207 | ||
| Increased gene expression of brown fat uncoupling protein (UCP)1 and skeletal muscle UCP2 and UCP3 in MAC16-induced cancer cachexia. | Q54209543 | ||
| Activation of UCPs gene expression in skeletal muscle can be independent on both circulating fatty acids and food intake. Involvement of ROS in a model of mouse cancer cachexia. | Q54683666 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 265-275 | |
| P577 | publication date | 2012-05-31 | |
| P1433 | published in | Journal of Cachexia, Sarcopenia and Muscle | Q6294897 |
| P1476 | title | Cancer cachexia is associated with a decrease in skeletal muscle mitochondrial oxidative capacities without alteration of ATP production efficiency | |
| P478 | volume | 3 |
| Q36213681 | Adipose tissue lipolysis and energy metabolism in early cancer cachexia in mice |
| Q45966636 | Amelioration of capillary regression and atrophy of the soleus muscle in hindlimb-unloaded rats by astaxanthin supplementation and intermittent loading. |
| Q37300041 | Association of genetic variants of ghrelin, leptin and UCP2 with malnutrition inflammation syndrome and survival in end-stage renal disease patients |
| Q43044556 | Cachexia: a problem of energetic inefficiency. |
| Q38290238 | Cancer cachexia syndrome: pathogenesis, diagnosis, and new therapeutic options |
| Q36685366 | Combination of exercise training and erythropoietin prevents cancer-induced muscle alterations |
| Q26866364 | Discerning primary and secondary factors responsible for clinical fatigue in multisystem diseases |
| Q41146515 | Disrupted Skeletal Muscle Mitochondrial Dynamics, Mitophagy, and Biogenesis during Cancer Cachexia: A Role for Inflammation |
| Q89967584 | Fat Wasting Is Damaging: Role of Adipose Tissue in Cancer-Associated Cachexia |
| Q42376081 | Growth hormone secretagogues hexarelin and JMV2894 protect skeletal muscle from mitochondrial damages in a rat model of cisplatin-induced cachexia |
| Q92988087 | Human Cachexia Induces Changes in Mitochondria, Autophagy and Apoptosis in the Skeletal Muscle |
| Q57056165 | Impact of Sarcopenia as a Prognostic Biomarker of Bladder Cancer |
| Q48155681 | Linking Cancer Cachexia-Induced Anabolic Resistance to Skeletal Muscle Oxidative Metabolism. |
| Q39733891 | Long-term exercise training prevents mammary tumorigenesis-induced muscle wasting in rats through the regulation of TWEAK signalling |
| Q99551651 | Lower Central Fat Increase Risk of One-Year Muscle Mass Loss in Menopausal Women |
| Q34648977 | Magnetic resonance imaging at 7T reveals common events in age-related sarcopenia and in the homeostatic response to muscle sterile injury |
| Q64275988 | Metabolic and Molecular Basis of Sarcopenia: Implications in the Management of Urothelial Carcinoma |
| Q60912250 | Metabolic derangements of skeletal muscle from a murine model of glioma cachexia |
| Q39085780 | Metabolism and Skeletal Muscle Homeostasis in Lung Disease. |
| Q33813591 | Mitochondria and ageing: role in heart, skeletal muscle and adipose tissue |
| Q41613604 | Mitochondria dysfunction in lung cancer-induced muscle wasting in C2C12 myotubes |
| Q92346171 | Mitochondrial respiration of complex II is not lower than that of complex I in mouse skeletal muscle |
| Q55301138 | Modulating Metabolism to Improve Cancer-Induced Muscle Wasting. |
| Q58229937 | Molecular insights into mitochondrial dysfunction in cancer-related muscle wasting |
| Q39001205 | Muscle wasting in ageing and chronic illness. |
| Q34156942 | Muscle wasting: an overview of recent developments in basic research |
| Q38631222 | Novel investigational drugs mimicking exercise for the treatment of cachexia |
| Q38626616 | Overexpression of uncoupling protein-2 in cancer: metabolic and heat changes, inhibition and effects on drug resistance |
| Q35690207 | Preserved muscle oxidative metabolic phenotype in newly diagnosed non-small cell lung cancer cachexia |
| Q55653938 | The AMPK agonist 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR), but not metformin, prevents inflammation-associated cachectic muscle wasting. |
| Q64226626 | The Skeletal Muscle as an Active Player Against Cancer Cachexia |
| Q39033683 | The role of adipose tissue in cancer-associated cachexia |
| Q99241345 | The wasting-associated metabolite succinate disrupts myogenesis and impairs skeletal muscle regeneration |
| Q39339489 | Understanding tumor anabolism and patient catabolism in cancer-associated cachexia |
Search more.